This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cornford, P. A. Articles by Foster, C. S. Search for Related Content PubMed PubMed Citation Articles by Cornford, P. A. Articles by Foster, C. S.

Heat Shock Protein Expression Independently Predicts Clinical Outcome in Prostate Cancer¹

Departments of Surgery [P. A. C., J. P. N.] and Pathology [A. R. D., Y. K., C. S. F.], The University of Liverpool, and Department of Urology, The Royal Liverpool University Hospital [P. A. C., K. F. P., A. D. D., A. W., M. F.], Liverpool, L69 3GA, United Kingdom

Heat shock proteins (hsps) occupy a central role in the regulation of intracellular homeostasis, and differential expression of individual hsps occurs in a broad range of neoplastic processes. This study was performed to test the hypothesis that the particular patterns by which individual hsps become specifically modulated in human prostate cancers are correlated with behavioral phenotype and hence may be of value in determining the most appropriate clinical management of individual patients. Monoclonal antibodies specific for each hsp protein were used to assess expression of hsp27, hsp60, and hsp70 in formalin-fixed, paraffin wax-embedded, archival tissue specimens of early prostatic adenocarcinomas (pT_1–2N_oM_o) removed at radical prostatectomy (n = 25) and in advanced cancers (n = 95) identified at transurethral resection of prostate (TURP). These findings were compared with similar data from control prostates (n = 10) removed at primary cystectomy for urinary bladder neoplasia not involving the prostate and also at TURP for benign prostatic hyperplasia (n = 50). Western blotting of whole cell lysates derived from established human prostatic epithelial cell lines PNT2, LNCaP, DU145, and PC3 was compared with expression of hsps by the primary human tissues. This study found that early in situ neoplastic transformation of normal prostatic epithelium was consistently associated with loss of hsp27 expression and that the level of hsp27 expression by individual prostate cancers was correlated with their Gleason grade. In advanced cancers, hsp27 expression was invariably associated with poor clinical outcome (P = 0.0001). Data from cell lines supported the primary tissue findings, with elevated hsp27 expression only in aggressive malignant cell lines and androgen-insensitive cell lines. Expression of hsp60 was significantly increased in both early and advanced prostate cancer when compared with nonneoplastic prostatic epithelium (P < 0.0001), as well as in malignant prostate cancer cell lines. Expression of hsp70 was unaltered in early prostate cancers when compared with nonneoplastic prostatic epithelium but showed a diminished expression in morphologically advanced cancers (P = 0.0029). No consistent correlation was found between levels of hsp60 or hsp70 expression and phenotypic behavior of individual primary prostatic cancers. Thus, patterns of hsp expression have been confirmed to be specifically and consistently modulated in both early and advanced human prostate cancers. Whereas absence of hsp27 is a reliable objective marker of early prostatic neoplasia, reexpression of this protein by an individual invasive prostatic carcinoma invariably heralds poor clinical prognosis. Because this protein has been shown to alter the balance between proliferation and apoptosis, understanding the mechanism(s) by which individual hsps regulate intracellular homeostasis may assist in explaining some key processes that occur during evolution of human prostate cancers. We suggest that hsp27 expression provides novel diagnostic and prognostic information on individual patient survival which, if obtained at the time of primary diagnosis, would assist in determining tumor-specific management strategies. Development of techniques to therapeutically modulate hsp27 expression raises the possibility of novel targeted approaches to regulate this homeostatic mechanism, thus allowing better control over tumor cell proliferation and hence patient survival.

This article has been cited by other articles:

				R. Ria, K. Todoerti, S. Berardi, A. M. L. Coluccia, A. De Luisi, M. Mattioli, D. Ronchetti, F. Morabito, A. Guarini, M. T. Petrucci, et al. Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma Clin. Cancer Res., September 1, 2009; 15(17): 5369 - 5378. [Abstract] [Full Text] [PDF]

				S. YOSHIDA, S. HAZAMA, K. TOKUNO, K. SAKAMOTO, M. TAKASHIMA, T. TAMESA, T. TORIGOE, N. SATO, and M. OKA Concomitant Overexpression of Heat-shock Protein 70 and HLA Class-I in Hepatitis C Virus-related Hepatocellular Carcinoma Anticancer Res, February 1, 2009; 29(2): 539 - 544. [Abstract] [Full Text] [PDF]

				M. Lakshman, L. Xu, V. Ananthanarayanan, J. Cooper, C. H. Takimoto, I. Helenowski, J. C. Pelling, and R. C. Bergan Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice Cancer Res., March 15, 2008; 68(6): 2024 - 2032. [Abstract] [Full Text] [PDF]

				T Qi, J Han, Y Cui, M Zong, X Liu, and B Zhu Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas J. Clin. Pathol., January 1, 2008; 61(1): 49 - 58. [Abstract] [Full Text] [PDF]

				A. Zoubeidi, A. Zardan, E. Beraldi, L. Fazli, R. Sowery, P. Rennie, C. Nelson, and M. Gleave Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity Cancer Res., November 1, 2007; 67(21): 10455 - 10465. [Abstract] [Full Text] [PDF]

				D. Chandra, G. Choy, and D. G. Tang Cytosolic Accumulation of HSP60 during Apoptosis with or without Apparent Mitochondrial Release: EVIDENCE THAT ITS PRO-APOPTOTIC OR PRO-SURVIVAL FUNCTIONS INVOLVE DIFFERENTIAL INTERACTIONS WITH CASPASE-3 J. Biol. Chem., October 26, 2007; 282(43): 31289 - 31301. [Abstract] [Full Text] [PDF]

				G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]

				M. Kamada, A. So, M. Muramaki, P. Rocchi, E. Beraldi, and M. Gleave Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells Mol. Cancer Ther., January 1, 2007; 6(1): 299 - 308. [Abstract] [Full Text] [PDF]

				L. Pootrakul, R. H. Datar, S.-R. Shi, J. Cai, D. Hawes, S. G. Groshen, A. S. Lee, and R. J. Cote Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer. Clin. Cancer Res., October 15, 2006; 12(20): 5987 - 5993. [Abstract] [Full Text] [PDF]

				L. Xu and R. C. Bergan Genistein Inhibits Matrix Metalloproteinase Type 2 Activation and Prostate Cancer Cell Invasion by Blocking the Transforming Growth Factor beta-Mediated Activation of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2-27-kDa Heat Shock Protein Pathway Mol. Pharmacol., September 1, 2006; 70(3): 869 - 877. [Abstract] [Full Text] [PDF]

				E. Malusecka, A. Zborek, S. Krzyzowska-Gruca, and Z. Krawczyk Immunohistochemical Detection of the Inducible Heat Shock Protein Hsp70: A Methodological Study J. Histochem. Cytochem., February 1, 2006; 54(2): 183 - 190. [Abstract] [Full Text] [PDF]

				X. Wang, M. A. Khaleque, M. J. Zhao, R. Zhong, M. Gaestel, and S. K. Calderwood Phosphorylation of HSF1 by MAPK-Activated Protein Kinase 2 on Serine 121, Inhibits Transcriptional Activity and Promotes HSP90 Binding J. Biol. Chem., January 13, 2006; 281(2): 782 - 791. [Abstract] [Full Text] [PDF]

				Y. Ma, V. Lakshmikanthan, R. W. Lewis, and M. V. Kumar Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin Mol. Cancer Ther., January 1, 2006; 5(1): 170 - 178. [Abstract] [Full Text] [PDF]

				K. D. Shin, M.-Y. Lee, D.-S. Shin, S. Lee, K.-H. Son, S. Koh, Y.-K. Paik, B.-M. Kwon, and D. C. Han Blocking Tumor Cell Migration and Invasion with Biphenyl Isoxazole Derivative KRIBB3, a Synthetic Molecule That Inhibits Hsp27 Phosphorylation J. Biol. Chem., December 16, 2005; 280(50): 41439 - 41448. [Abstract] [Full Text] [PDF]

				P. Rocchi, E. Beraldi, S. Ettinger, L. Fazli, R. L. Vessella, C. Nelson, and M. Gleave Increased Hsp27 after Androgen Ablation Facilitates Androgen-Independent Progression in Prostate Cancer via Signal Transducers and Activators of Transcription 3-Mediated Suppression of Apoptosis Cancer Res., December 1, 2005; 65(23): 11083 - 11093. [Abstract] [Full Text] [PDF]

				H. Methe, J.-O. Kim, S. Kofler, M. Weis, M. Nabauer, and J. Koglin Expansion of Circulating Toll-Like Receptor 4-Positive Monocytes in Patients With Acute Coronary Syndrome Circulation, May 24, 2005; 111(20): 2654 - 2661. [Abstract] [Full Text] [PDF]

				G. Gannot, J. W. Gillespie, R. F. Chuaqui, M. A. Tangrea, W. M. Linehan, and M. R. Emmert-Buck Histomathematical Analysis of Clinical Specimens: Challenges and Progress J. Histochem. Cytochem., February 1, 2005; 53(2): 177 - 185. [Abstract] [Full Text] [PDF]

				P. Rocchi, A. So, S. Kojima, M. Signaevsky, E. Beraldi, L. Fazli, A. Hurtado-coll, K. Yamanaka, and M. Gleave Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer Cancer Res., September 15, 2004; 64(18): 6595 - 6602. [Abstract] [Full Text] [PDF]

				Y. Wang, J. R. Theriault, H. He, J. Gong, and S. K. Calderwood Expression of a Dominant Negative Heat Shock Factor-1 Construct Inhibits Aneuploidy in Prostate Carcinoma Cells* J. Biol. Chem., July 30, 2004; 279(31): 32651 - 32659. [Abstract] [Full Text] [PDF]

				S. C.G. Hollestelle, M. R. de Vries, J. K. van Keulen, A. H. Schoneveld, A. Vink, C. F. Strijder, B. J. van Middelaar, G. Pasterkamp, P. H.A. Quax, and D. P.V. de Kleijn Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling Circulation, January 27, 2004; 109(3): 393 - 398. [Abstract] [Full Text] [PDF]

				D. Chauhan, G. Li, T. Hideshima, K. Podar, C. Mitsiades, N. Mitsiades, L. Catley, Y. T. Tai, T. Hayashi, R. Shringarpure, et al. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance Blood, November 1, 2003; 102(9): 3379 - 3386. [Abstract] [Full Text] [PDF]

				L. Shatkina, S. Mink, H. Rogatsch, H. Klocker, G. Langer, A. Nestl, and A. C. B. Cato The Cochaperone Bag-1L Enhances Androgen Receptor Action via Interaction with the NH2-Terminal Region of the Receptor Mol. Cell. Biol., October 15, 2003; 23(20): 7189 - 7197. [Abstract] [Full Text] [PDF]

				D. de Kleijn and G. Pasterkamp Toll-like receptors in cardiovascular diseases Cardiovasc Res, October 15, 2003; 60(1): 58 - 67. [Abstract] [Full Text] [PDF]

				G. S. Missotten, J. G. J.-d. Korver, D. de Wolff-Rouendaal, J. E. Keunen, R. O. Schlingemann, and M. J. Jager Heat Shock Protein Expression in the Eye and in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3059 - 3065. [Abstract] [Full Text] [PDF]

				H. Sakamoto, T. Mashima, K. Yamamoto, and T. Tsuruo Modulation of Heat-shock Protein 27 (Hsp27) Anti-apoptotic Activity by Methylglyoxal Modification J. Biol. Chem., November 22, 2002; 277(48): 45770 - 45775. [Abstract] [Full Text] [PDF]